Equities

RadNet Inc

RadNet Inc

Actions
Health CareHealth Care Providers
  • Price (USD)81.30
  • Today's Change-0.86 / -1.05%
  • Shares traded315.53k
  • 1 Year change+156.47%
  • Beta1.7581
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

RadNet, Inc. is a national provider of fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States. It has a network of 366 owned and/or operated outpatient imaging centers. The Company’s Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Company’s Artificial Intelligence (AI) segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate and pulmonary diagnostics. The Company, through its joint ventured Arizona Diagnostic Radiology Group, LLC, owns seven outpatient imaging centers.

  • Revenue in USD (TTM)1.77bn
  • Net income in USD-4.41m
  • Incorporated2008
  • Employees7.87k
  • Location
    RadNet Inc1510 Cotner AveLOS ANGELES 90025United StatesUSA
  • Phone+1 (310) 478-7808
  • Fax+1 (302) 636-5454
  • Websitehttps://www.radnet.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
RDNT:NMQ since
announced
Transaction
value
Houston Medical Imaging LLCAnnounced21 Feb 202421 Feb 2024Announced115.59%--
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Brightspring Health Services Inc10.59bn-40.60m3.27bn35.00k--2.0320.780.309-0.2623-0.262360.439.281.8821.1311.14302,520.40-0.765---0.9652--14.5017.75-0.4073-0.62890.97421.130.6247--14.3228.33-186.80--17.24--
Acadia Healthcare Company Inc3.12bn280.73m3.63bn23.50k12.801.188.331.163.053.0533.9933.040.5568--8.36183,677.905.182.326.102.64----9.315.601.065.090.3738--12.208.99-107.93--3.34--
Option Care Health Inc4.78bn208.87m3.72bn5.81k18.312.6113.760.77961.191.1927.328.381.4313.4711.77822,202.406.263.637.914.3520.7622.454.372.781.327.060.4380.009.0643.4277.40--24.72--
Sotera Health Co1.12bn70.49m3.74bn3.00k53.277.9615.933.340.2480.2483.941.660.362310.977.36373,492.302.29-0.8682.44-0.966455.1654.406.31-2.682.612.200.8319--4.547.06121.87--24.24--
Hims & Hers Health Inc1.24bn101.26m4.76bn1.05k50.3710.7941.413.830.43260.43265.452.022.446.59282.181,187,375.0019.93--25.93--81.13--8.15--1.82--0.00--65.49--64.15------
Select Medical Holdings Corp6.97bn265.80m4.91bn38.40k17.832.588.670.70512.142.1456.1014.780.8885--6.95181,472.604.524.195.635.4614.4213.985.095.11--4.530.578415.305.225.5753.0311.986.50--
Radnet Inc1.77bn-4.41m6.08bn7.87k--6.7936.803.43-0.0654-0.065424.8112.100.5946--8.41225,221.801.031.241.311.6623.3821.561.731.86--1.380.47660.0013.0510.64-71.42-37.6319.60--
CorVel Corp845.64m81.52m6.08bn4.87k75.5121.5355.627.194.704.7048.8016.501.78--8.93173,642.3017.1114.8729.4724.2121.8122.149.649.16----0.000.0010.685.9514.9010.5713.87--
Chemed Corp2.38bn301.73m8.28bn15.09k27.956.6822.733.4819.7819.78155.8282.781.43136.4913.04157,566.5018.1119.5321.7924.6435.6634.6012.6912.601.81--0.008.156.064.909.175.801.466.10
Ensign Group Inc4.11bn239.98m8.29bn35.30k35.014.7425.792.024.134.1370.8630.500.9433--8.01116,391.305.526.456.637.8821.1922.325.856.48----0.07736.5623.2716.28-6.8028.624.405.02
Data as of Nov 21 2024. Currency figures normalised to RadNet Inc's reporting currency: US Dollar USD

Institutional shareholders

41.72%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20248.73m11.80%
The Vanguard Group, Inc.as of 30 Sep 20247.16m9.68%
Beck, Mack & Oliver LLCas of 30 Sep 20243.20m4.33%
SSgA Funds Management, Inc.as of 30 Sep 20242.45m3.31%
RTW Investments LPas of 30 Sep 20241.81m2.45%
Dimensional Fund Advisors LPas of 30 Sep 20241.67m2.25%
Geode Capital Management LLCas of 30 Sep 20241.56m2.10%
Principal Global Investors LLCas of 30 Sep 20241.51m2.04%
Alan W. Weber (Investment Management)as of 30 Sep 20241.50m2.03%
Hood River Capital Management LLCas of 30 Sep 20241.28m1.74%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.